Avignon A - Search Results

1

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

Avignon A, Sultan A, Piot C, Elaerts S, Cristol JP, Dupuy AM. Avignon A, et al. Diabetes Care. 2005 Sep;28(9):2176-80. doi: 10.2337/diacare.28.9.2176. Diabetes Care. 2005. PMID: 16123486

2

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

Avignon A, Radauceanu A, Monnier L. Avignon A, et al. Diabetes Care. 1997 Dec;20(12):1822-6. doi: 10.2337/diacare.20.12.1822. Diabetes Care. 1997. PMID: 9405900

3

[Changes in dietary management of diabetic patients].

Monnier L, Colette C, Avignon A, Percheron C, Lapinski H, Boniface H. Monnier L, et al. Among authors: avignon a. Diabetes Metab. 1998 Nov;24 Suppl 3:24-34. Diabetes Metab. 1998. PMID: 9881229 Review. French.

4

Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin.

Avignon A, Lapinski H, Rabasa-Lhoret R, Caubel C, Boniface H, Monnier L. Avignon A, et al. Diabetes Obes Metab. 2000 Aug;2(4):229-35. doi: 10.1046/j.1463-1326.2000.00082.x. Diabetes Obes Metab. 2000. PMID: 11225656

5

Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes.

Monnier L, Colette C, Rabasa-Lhoret R, Lapinski H, Caubel C, Avignon A, Boniface H. Monnier L, et al. Among authors: avignon a. Diabetes Care. 2002 Apr;25(4):737-41. doi: 10.2337/diacare.25.4.737. Diabetes Care. 2002. PMID: 11919134

6

Inflammatory parameters are independent predictors of severe epicardial coronary stenosis in asymptomatic diabetic patients with silent myocardial ischemia.

Piot C, Fontbonne A, Sultan A, Rasamisoa M, Mariano-Goulart D, Davy JM, Monnier L, Avignon A. Piot C, et al. Among authors: avignon a. Diabetes Care. 2003 Feb;26(2):545-6. doi: 10.2337/diacare.26.2.545-a. Diabetes Care. 2003. PMID: 12547901 No abstract available.

7

Risk factors for silent myocardial ischemia in high-risk type 1 diabetic patients.

Sultan A, Piot C, Mariano-Goulart D, Rasamisoa M, Renard E, Avignon A. Sultan A, et al. Among authors: avignon a. Diabetes Care. 2004 Jul;27(7):1745-7. doi: 10.2337/diacare.27.7.1745. Diabetes Care. 2004. PMID: 15220258 No abstract available.

8

Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France.

Sultan A, Piot C, Mariano-Goulart D, Daures JP, Comte F, Renard E, Avignon A. Sultan A, et al. Among authors: avignon a. Diabet Med. 2006 Apr;23(4):410-8. doi: 10.1111/j.1464-5491.2006.01818.x. Diabet Med. 2006. PMID: 16620270

9

PKC-B inhibition: a new therapeutic approach for diabetic complications?

Avignon A, Sultan A. Avignon A, et al. Diabetes Metab. 2006 Jun;32(3):205-13. doi: 10.1016/s1262-3636(07)70270-7. Diabetes Metab. 2006. PMID: 16799396 Review.

10

Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?

Sultan A, Thuan JF, Avignon A. Sultan A, et al. Among authors: avignon a. Diabetes Metab. 2006 Dec;32(6):559-67. doi: 10.1016/S1262-3636(07)70310-5. Diabetes Metab. 2006. PMID: 17296509 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters